NCT06651892View on ClinicalTrials.gov

The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in The Treatment of Hypophosphatemia in ICU Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Acute Hypophosphatemia
Interventions
DRUG

Enema Phosphates Sodium

oral diluted phosphate enema containing as a repletion strategy to replace phosphate in critically ill patients with acute hypophosphatemia.

DRUG

Glycophos Injectable Product

intravenous sodium glycerophosphate as the standard of care or active control

Trial Locations (1)

Unknown

Al haram Hospital, Giza

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06651892 - The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in The Treatment of Hypophosphatemia in ICU Patients | Biotech Hunter | Biotech Hunter